NEW STEP BY STEP MAP FOR HEMGENIX

Quantity of eligible individuals: CDEC mentioned the uncertainty in the amount of sufferers with moderately extreme to extreme hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical experts consulted by CADTH indicated that some patients who will be labeled as acquiring delicate or moderate illness may have a severe bleeding phenot